Healthcare & Life Sciences
Atsena Therapeutics
United Statesatsenatx.com/
Atsena Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B.
Activeseries-b
series-b
Stage
About Atsena Therapeutics
Atsena Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
Atsena Therapeutics is a clinical-stage gene therapy company developing genetic medicines to treat inherited retinal diseases such as X-linked retinoschisis, Leber congenital amaurosis 1, Usher Syndrome 1B, and Stargardt disease, focusing on ocular gene therapies with proprietary AAV vector technology.
Explore Atsena Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.